Bharat Biotech said on Wednesday it had submitted data from its Covid-19 vaccine trial in children aged 2 to 18 years to the drug regulator, becoming the country's first company to have tested its shot in very young children.
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
The Drugs Controller General of India last month allowed vaccine maker Serum Institute to enroll kids aged 7 to 11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
So far, only drugmaker Zydus Cadila's DNA-based COVID-19 vaccine has received emergency use approval in India to be used in adults and children aged atleast 12 years.
Dominica To Award Its Highest National Honour To PM Modi Tuberculosis Replaces Covid As Top Infectious Disease Killer, Says WHO What Is A Tripledemic? Lookout For These Three Viruses That Cause Severe Respiratory Health Issues "Thousand Times Better...": Delhi Lt Governor's Surprise For AAP's Atishi "World War 3 Has Begun": Ukraine Ex-Military Commander Amid Russia Conflict Elon Musk Slams 'Ridiculously Slow And Difficult' US Immigration System US Reports First Case Of Bird Flu In A Child Kerala High Court Criticises LDF, UDF For "Irresponsible" Hartals In Wayanad N Sitharaman Urges India To Defy Western Diktats To Build "Brand Bharat" Track Latest News Live on NDTV.com and get news updates from India and around the world.